Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Diphenhydramine recalled?

Yes — there is an active recall. 8 ongoing FDA recalls mention Diphenhydramine (49 total). Check the affected lots below.

Most common reason: Microbial contamination (14 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Diphenhydramine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Diphenhydramine recalls on record

none so far in 2026; 49 on record, newest first
Class II · Moderate risk

Unisom

CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit

Ongoing Nitrosamine impurity Chattem Inc D-0362-2025
Class II · Moderate risk

Unisom

CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.

Ongoing Nitrosamine impurity Chattem Inc D-0266-2025
Class III · Low risk

Diphenhydramine HCl 50 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8026-02 D-0199-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-2 D-0198-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-1 D-0197-2025
Class II · Moderate risk

CORRECTDOSE Children's ALLERGY RELIEF

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 62320-302-05 D-1492-2022
Class II · Moderate risk

Diphenhydramine HCl Oral Solution

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6741-72 D-1489-2022
Class II · Moderate risk

Diphenhydramine HCL Liquid

Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination H J Harkins Company Inc dba Pharma Pac NDC 52959-0123-03 D-1430-2019
Class II · Moderate risk

Diphenhist Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1370-2019
Class II · Moderate risk

Banophen Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1352-2019